Zum Inhalt springen
Likelier

Handeln vs. Nichthandeln: Zahl für jede Wahl

Geschlechtsangleichende Behandlung in Anspruch nehmen vs. ohne medizinische Behandlung leben

Wenn du handelst

Geschlechtsangleichende Behandlung verfolgen

3,0%

Wenn du nicht handelst

Ohne geschlechtsangleichende Behandlung leben

Keine direkte Messung

Mindestens eine Zahl ist eine indirekte Schätzung, keine gemessene Reuequote. Wie jede Zahl entstanden ist, steht weiter unten.


Gesundheit

Zuletzt überprüft 2026-05-04

Evidenzqualität 4.5/5

Bewertungsergebnis nach acht Dimensionen gemäß der Qualitätsrubrik . Jede Dimension wird mit 1–5 bewertet.

D1 Quellenüberprüfung
4/5
D2 Quellenautorität & Unabhängigkeit
5/5
D3 Genauigkeit der Bedauernsrate
3/5
D4 Vergleichbarkeit der Quellen
4/5
D5 Gilovich-Muster
5/5
D6 Prosaqualität
5/5
D7 Vollständigkeit der Einschränkungen
5/5
D8 Stichprobenqualität
5/5
Durchschnitt 4.5/5
A flat vector illustration of a simple mirror reflecting a clear calm image, muted tones
Indirekte Daten: Für diese Entscheidung stammt mindestens eine Zahl aus einem indirekten Maß wie Folgen, Zufriedenheit oder Absicht oder aus einer redaktionellen Schätzung statt aus einer Umfrage, die direkt nach Reue fragt. Die Hinweise zu beiden Seiten weiter unten erklären, wie die jeweilige Zahl entstanden ist.

Wenn du handelst

Geschlechtsangleichende Behandlung verfolgen

3,0%

~2–4% der Empfänger geschlechtsangleichender Operationen berichten Bedauern; die Bedauernsraten für Hormone allein sind niedriger

Transgender und nicht-binäre Erwachsene, die geschlechtsangleichende medizinische Versorgung erhielten (Expósito-Campos 2021, systematische Übersicht; WPATH SOC v8, Evidenzübersicht)

Nachbeobachtung nach Behandlung (variabel, 1–30 Jahre)

Wenn du nicht handelst

Ohne geschlechtsangleichende Behandlung leben

Keine direkte Messung

Keine Quelle nennt für diese Seite eine Zahl, deshalb zeigen wir keine.

Transgender und geschlechtsdiverse Erwachsene ohne Zugang zu oder mit Verzögerung der geschlechtsangleichenden Versorgung (US Transgender Survey 2022; Turban et al. 2020)

Querschnitt und retrospektiv; Erwachsenenalter

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Verwandte Entscheidungen

Semantisch ähnliche Entscheidungen — gleiches Terrain, andere Abwägungen.

Gesundheit

Korea: Schönheits-OP vs. ablehnen

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Brustvergrößerung

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Langlebigkeit vs Altern akzeptieren

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Therapie oder keine Therapie

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

DNA-Test Abstammung/Gesundheit vs. verzichten

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Schönheitschirurgie

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Nur Alternativmedizin vs. konventionell

Zahl für jede Wahl (was sie misst, steht auf der Seite)

Gesundheit

Fruchtbarkeitsbehandlung vs. Kinderlosigkeit

Zahl für jede Wahl (was sie misst, steht auf der Seite)

No survey directly measures the regret of adults who want gender-affirming care and live without it, so this side has no direct measurement, which is why this entry is flagged as proxy-only. The evidence is indirect. Turban et al.’s 2020 Pediatrics study of 20,619 transgender adults looked at those who had ever wanted pubertal suppression. The people who received it had markedly lower odds of lifetime suicidal ideation (adjusted OR 0.3) than those who wanted it but could not access it. The 2022 U.S. Transgender Survey is the largest survey of transgender people in US history, with 92,329 respondents. Nearly all care recipients said the care made them more satisfied with their lives: 98% of those receiving gender-affirming hormone therapy and 97% of those receiving transition-related surgery.

Bustos et al.’s 2021 systematic review and meta-analysis pooled 27 studies covering 7,928 patients who underwent gender-affirming surgery. The pooled regret prevalence was 1% (95% CI <1%–2%). That is consistent with the 1–4% range seen in contemporary cohorts, as patient selection and surgical techniques have improved. Regret after hormonal treatment alone is lower than after surgery. The action-side rate of 3% is a conservative estimate, since it uses the upper end of the contemporary surgical range rather than the 1% mean across all studies.

The clinical evidence on outcomes is now extensive and consistent. WPATH Standards of Care Version 8 (2022) is the most comprehensive systematic review of it. It confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety and suicidality in transgender and gender diverse adults. Set against the high satisfaction among care recipients, the surgical-regret rate is very low.

The entry concerns one population: adults with gender dysphoria who want treatment and are weighing whether to pursue it. For them the evidence consistently shows rare regret after care. People uncertain about their gender identity are outside this decision frame. Their question is different, and the evidence base for it is sparser. WPATH SOC v8 addresses the difference by recommending thorough psychological assessment before surgical interventions, though not necessarily before hormonal ones. That is the clinical standard under which the 1–4% regret rates in published studies were achieved. The regret data reflect outcomes under that assessment standard, not outcomes under zero clinical gatekeeping.

Quellen: Handeln

Quellenregister

Jede Zahl unten ist das, was die jeweilige Quelle berichtet hat — mit dem wörtlichen Zitat, auf das wir uns stützen, und wie wir zu unserer Zahl gelangt sind. Klicke auf einen Link, um direkt zu prüfen.

1/2 Quellen unabhängig wortwörtlich mit der zitierten Quelle abgeglichen

  1. [1] International Journal of Transgender Health / WPATH — Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
    Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
    Statistik
    Systematic evidence review confirms gender-affirming care significantly reduces gender dysphoria, depression, anxiety, and suicidality; regret rates for gender-affirming surgery in recent cohorts: 1–4%
    Auszug
    “"The WPATH Standards of Care Version 8 evidence review confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety, and suicidality in transgender and gender diverse adults. Regret rates for gender-affirming surgery, based on studies from multiple countries and time periods, range from approximately 1 to 4 percent in contemporary cohorts, with declining regret rates over time as patient selection criteria and surgical techniques have improved. Studies consistently find that the absence of gender-affirming care is associated with substantially worse mental health outcomes than receipt of care." ”
    Quelldaten von
    2022-09-15
    Abgerufen
    2026-05-04
    Berechnung
    WPATH SOC v8 (Coleman et al. 2022). The comprehensive WPATH evidence review is the primary authoritative source for this entry. The 1–4% surgical regret range is used; the 3% midpoint is the action-side regret_rate. Regret rates for hormones alone are lower (estimated <2%), so the 3% is a conservative upper bound reflecting the surgical-care subgroup.
  2. [2] Plastic and Reconstructive Surgery — Global Open — Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence Verifiziert
    Regret after Gender-affirmation Surgery: A Systematic Review and Meta-analysis of Prevalence
    Statistik
    Systematic review and meta-analysis of 27 studies pooling 7,928 transgender patients who underwent gender-affirming surgery: pooled prevalence of regret 1% (95% CI <1%–2%)
    Auszug
    “"A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%–2%)." ”
    Quelldaten von
    2021-03-19
    Abgerufen
    2026-05-04
    Verifizierung
    Der Auszug wurde bei unserer Grounding-Prüfung unabhängig erneut abgerufen und Wort für Wort mit der zitierten Quelle abgeglichen.
    Berechnung
    Bustos VP, Bustos SS, Mascaro A, et al. 2021, Plastic and Reconstructive Surgery Global Open 9(3):e3477 (DOI 10.1097/GOX.0000000000003477; PMID 33968550; PMC8099405) — systematic review and meta-analysis of 27 studies, 7,928 patients. The pooled regret prevalence of 1% (95% CI <1%–2%) is below the 3% action-side regret_rate; combined with the WPATH SOC v8 1–4% contemporary-surgery range, the 3% rate is used as a conservative upper bound for the surgical-care subgroup.

Quellen: Nichthandeln

Quellenregister

Jede Zahl unten ist das, was die jeweilige Quelle berichtet hat — mit dem wörtlichen Zitat, auf das wir uns stützen, und wie wir zu unserer Zahl gelangt sind. Klicke auf einen Link, um direkt zu prüfen.

1/2 Quellen unabhängig wortwörtlich mit der zitierten Quelle abgeglichen

  1. [1] Pediatrics — Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation Verifiziert
    Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation
    Statistik
    Cross-sectional survey of 20,619 transgender adults; among the 16.9% (3,494) who ever wanted pubertal suppression, those who received it had lower odds of lifetime suicidal ideation than those who wanted but did not receive it (adjusted OR = 0.3; 95% CI 0.2–0.6)
    Auszug
    “"Using a cross-sectional survey of 20 619 transgender adults aged 18 to 36 years ... Of the sample, 16.9% reported that they ever wanted pubertal suppression as part of their gender-related care ... those who received treatment with pubertal suppression, when compared with those who wanted pubertal suppression but did not receive it, had lower odds of lifetime suicidal ideation (adjusted odds ratio = 0.3; 95% confidence interval = 0.2–0.6). ... There is a significant inverse association between treatment with pubertal suppression during adolescence and lifetime suicidal ideation among transgender adults who ever wanted this treatment." ”
    Quelldaten von
    2020-02-01
    Abgerufen
    2026-05-04
    Verifizierung
    Der Auszug wurde bei unserer Grounding-Prüfung unabhängig erneut abgerufen und Wort für Wort mit der zitierten Quelle abgeglichen.
    Berechnung
    Turban et al. 2020, Pediatrics 145(2):e20191725 (DOI 10.1542/peds.2019-1725; PMID 31974216; PMC7073269). Among the 3,494 transgender adults who ever wanted pubertal suppression, those who received it had markedly lower odds of lifetime suicidal ideation (aOR 0.3; CI 0.2–0.6) than those who wanted it but could not access it. This documents the elevated psychological burden borne by people who want but cannot obtain desired gender-affirming care, contextualising the inaction-side regret rate.
  2. [2] Advocates for Trans Equality (formerly National Center for Transgender Equality) — US Trans Survey
    US Trans Survey
    Statistik
    Largest US survey of transgender people (92,329 respondents): nearly all respondents who received gender-affirming care reported it made them more satisfied with their lives — gender-affirming hormone therapy 98%, transition-related surgeries 97%
    Auszug
    “"Among those who accessed them, nearly all respondents said that gender-affirming hormone therapy (98%) or transition-related surgeries (97%) made them more satisfied with their lives." ”
    Quelldaten von
    2024-02-08
    Abgerufen
    2026-05-04
    Berechnung
    2022 U.S. Transgender Survey, findings page (Advocates for Trans Equality; 92,329 respondents, the largest survey of transgender people in US history). The survey measures satisfaction, not direct regret: 98% of those receiving gender-affirming hormone therapy and 97% of those receiving transition-related surgery said it made them more satisfied with their lives. The near-universal satisfaction among care recipients is the satisfaction proxy underlying the large action–inaction gap on this entry; the inaction-side rate is a derived proxy for the burden borne by those who want but cannot access desired care, not a direct regret-survey figure.

Einschränkungen

This entry reflects the current state of the clinical evidence base for adults, as summarised in WPATH SOC v8 (2022) and the systematic literature. The action-side regret rate (3%) is for surgical care; regret rates for hormones alone are lower. The inaction side has no direct measurement and is a modeled proxy, not a measured regret figure: no survey directly asks transgender adults how many regret not accessing desired care. The available evidence is indirect — near-universal satisfaction among care recipients (98% for hormones, 97% for surgery in the 2022 U.S. Transgender Survey) and lower suicidal ideation among those who obtained desired pubertal suppression. The proxy applies specifically to adults who wanted treatment but had not received it — not to those uncertain about their gender identity or who have chosen not to seek care. These are meaningfully different populations, and this entry is flagged proxy-only. The evidence base is more limited for adolescents than for adults; the SOC v8 has separate recommendations for youth that include additional assessment requirements. The surgical-regret data comes predominantly from European cohorts (Netherlands, Sweden, Belgium) and the Bustos meta-analysis spanning 14 countries; populations in countries where gender-affirming care is restricted or criminalised face different decision structures. The consistent finding across dozens of studies is that regret after gender-affirming care is rare; this reflects the clinical literature and is not a policy position. The entry does not address which specific interventions are appropriate for specific individuals, which is a clinical determination requiring individualised assessment.

Rohdaten: /api/decisions.json

Zuletzt auf diesem Gerät angesehen